Physician profile
Matthew Smith
NPI 1275869729
$801.90
in general payments reported to CMS, 2019-2025
8 companies · $17.35 in 2025
The $17.35 reported for 2025 was less than what a typical Diagnostic Radiology provider received nationally (typical 2025 total: $112).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $24.47 · 2020: $15.00 · 2022: $650 · 2023: $53.31 · 2024: $41.77 · 2025: $17.35.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $112.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $112.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Access Vascular INC | $650.00 | 2022 | |
| Argon Medical Devices, INC. | $53.31 | 2023 | Tips |
| Sun Pharmaceutical Industries INC. | $21.78 | 2024 | |
| Janssen Biotech, INC. | $19.99 | 2024 | Stelara |
| Stryker Corporation | $17.35 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Bard Peripheral Vascular, INC. | $15.00 | 2020 | |
| Merck Sharp & Dohme LLC | $13.07 | 2019 | |
| Alkermes, INC. | $11.40 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.